Related Experiment Videos
Some aspects of slow-acting drugs in rheumatoid arthritis
Agents and Actions. Supplements
|January 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rheumatic disease mimics in childhood.
Current opinion in rheumatology·2000
Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
The Journal of rheumatology·2000
Prognosis in juvenile arthritis.
Advances in experimental medicine and biology·1999
Children with chronic arthritis: the management of transition to adulthood.
Bailliere's clinical rheumatology·1999
Vasculitis in children and adolescents.
Rheumatic diseases clinics of North America·1995
Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.
Agents and actions. Supplements·1998
Immunomodulation of Crohn's disease by interleukin-10.
Agents and actions. Supplements·1998
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.
Agents and actions. Supplements·1998
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
Agents and actions. Supplements·1998
A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.
Agents and actions. Supplements·1998
CD40 and its ligand in cell-mediated immunity.
Agents and actions. Supplements·1998
Systematic allergological evaluation enables NSAID allergy delabeling and identification of safe alternatives in adults.
Allergologia et immunopathologia·2026
Canada's crackdown on poppers and trends in crystal methamphetamine use among sexual and gender diverse men: a secondary data analysis.
The International journal on drug policy·2026
A Look Back at Mercury Soap as a Treatment for Yaws.
The American Journal of dermatopathology·2026
Chelidonium majus L. alkaloid extract encapsulated in human serum albumin nanoparticles induces mitochondria-mediated apoptosis in HeLa cell line.
Cellular and molecular biology (Noisy-le-Grand, France)·2026
Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.
Rheumatology (Oxford, England)·2026